CVS vs STRO
CVS Health Corp (CVS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CVS and STRO stock pages for the full models.
Not investment advice.